| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.1M | +2.0% |
| Cost of Revenue | $7.2M | -20.1% |
| Gross Profit | $11.9M | +22.5% |
| R&D Expense | $1.6M | +19.2% |
| SG&A Expense | $9.1M | +11.9% |
| Operating Income | $1.2M | +367.5% |
| Pre-tax Income | $1.3M | +239.1% |
| Income Tax | -$219K | -149.0% |
| Net Income | $1.5M |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.8M | +383.5% |
| Accounts Receivable | $1.4M | -40.3% |
| Inventory | $3.5M | +80.4% |
| Current Assets | $17.5M | +52.0% |
| Total Assets | $22.8M | +30.3% |
| Current Liabilities | $7.3M | +66.6% |
| Total Liabilities | $11.1M | +52.4% |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.2M | +256.8% |
| Capital Expenditures | $3.4M | +427.8% |
| Investing Cash Flow | $1.9M | +165.0% |
| Financing Cash Flow | $1.3M | +477.2% |
| Free Cash Flow | -$1.2M | +42.3% |
| +2064.0% |
| EPS (Basic) | $0.19 | +2000.0% |
| EPS (Diluted) | $0.19 | +2000.0% |
| Stockholders' Equity |
| $11.7M |
| +14.5% |